Plain-English translation of NCT06940141 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called rademikibart to see if it can help people recover more quickly when they're having a severe asthma attack. The medication would be given in addition to the standard emergency care you'd normally receive (like steroids and breathing treatments). Researchers want to know if this treatment works well and is safe for people whose asthma involves high levels of a specific type of inflammation.
Even with current treatments, some people continue to struggle with severe asthma attacks that require emergency care. This medication is designed to target the specific type of inflammation that drives these attacks, and researchers hope it could help people feel better faster and prevent future emergencies.
You likely qualify if…
You likely don't qualify if…
When you arrive at the urgent care or emergency room with an asthma attack, you would be randomly assigned (like a coin flip) to receive either the new medication or a placebo (inactive treatment), both given on top of the standard emergency care everyone gets. The study team would monitor you during your emergency visit and follow up with you afterward to see how you're recovering and check for any side effects. The trial is designed to be relatively short-term, focusing on what happens during and immediately after your acute asthma attack.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States